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We previously showed that erythrocyte and brain spectrins bind phospholipid vesicles and monolayers prepared from phosphatidylethanol-
amine and phosphatidylserine and their mixtures with phosphatidylcholine (Review: A.F. Sikorski, B. Hanus-Lorenz, A. Jezierski, A. R.
Dluzewski, Interaction of membrane skeletal proteins with membrane lipid domain, Acta Biochim. Polon. 47 (2000) 565). Here, we show how
changes in the fluidity of the phospholipid monolayer affect spectrin–phospholipid interaction. The presence of up to 10%–20% cholesterol in the
PE/PC monolayer facilitates the penetration of the monolayer by both types of spectrin. For monolayers constructed from mixtures of PI/PC and
cholesterol, the effect of spectrins was characterised by the presence of two maxima (at 5 and 30% cholesterol) of surface pressure for erythroid
spectrin, and a single maximum (at 20% cholesterol) for brain spectrin. The binding assay results indicated a small but easily detectable decrease
in the affinity of erythrocyte spectrin for FAT-liposomes prepared from a PE/PC mixture containing cholesterol, and a 2- to 5-fold increase in
maximal binding capacity (Bmax) depending on the cholesterol content. On the other hand, the results from experiments with a monolayer
constructed from homogenous synthetic phospholipids indicated an increase in Dp change with the increase in the fatty acyl chain length of the
phospholipids used to prepare the monolayer. This was confirmed by the results of a pelleting experiment. Adding spectrins into the subphase of
raft-like monolayers constructed from DOPC, SM and cholesterol (1/1/1) induced an increase in surface pressure. The Dp change values were,
however, much smaller than those observed in the case of a natural PE/PC (6/4) monolayer. An increased binding capacity for spectrins of
liposomes prepared from a ‘‘raft-like’’ mixture of lipids could also be concluded from the pelleting assay. In conclusion, we suggest that the effect
of membrane lipid fluidity on spectrin–phospholipid interactions is not simple but depends on how it is regulated, i.e., by cholesterol content or by
the chemical structure of the membrane lipids.
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The membrane skeleton is a network of spectrin tetramers
cross-linked by actin filaments associated with the plasma
membrane via a variety of protein receptors, i.e. ankyrin or
protein 4.1. Erythrocyte spectrin and its non-erythroid analo-
gues can also interact directly and independently with the lipid
domain in natural membranes or in model systems [2–10],
review: ref. [1]. It was found that both spectrins bind directly to
liposomes containing the aminophospholipids PE and PS, andta 1758 (2006) 4 – 12
http://www
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inducing an increase in monolayer surface pressure [1]. We
previously demonstrated the interaction of erythrocyte and brain
spectrin with a class of membrane sites (present in erythrocyte
and synaptic plasma membranes) that proved resistant to
extraction with NaOH and protease treatment. Moreover, this
binding was competitively inhibited by liposomes prepared
from membrane lipids [10]. The data from recent studies
concerning direct interactions of erythroid and non-erythroid
spectrins with phospholipids, in particular PS, imply that
multiple binding sites for lipids exist in both subunits (a and
h) of erythroid and non-erythroid spectrins [11,12]. The
physiological significance of these interactions remains unclear.
On the other hand, the data from our laboratory indicate that one
of the lipid-binding sites, located in the region of carboxyl
terminus of the h-spectrin, proved sensitive to inhibition by
purified erythrocyte ankyrin [10,13,14]. This indicates that the
15th repeat of the h-subunit, which is an ankyrin-binding
domain, plays an important role in the interaction with
membrane lipids. One of the possible roles of this interaction
would be to serve as an alternative binding site when there is not
enough functional ankyrin to accommodate all the spectrin
tetramers in the membrane, or when ankyrin’s spectrin-binding
affinity is reduced, e.g., upon its phosphorylation [1].
Many authors attempted to determine the mechanism of
spectrin–lipid interaction and the phospholipid selectivity of
spectrins, but the results did not allow for full understanding
of the mechanism of interaction (Review: [1]). Therefore, we
decided to address the question whether changes in the fluidity
of the phospholipid monolayer affect spectrin–phospholipid
interaction. Another important issue is the occurrence of lipid
rafts—specialized domains into which most cellular plasma
membranes are organised [15,16]. Therefore, the interaction of
both types of spectrin with monolayers prepared from a ‘‘raft-
like’’ lipid mixture was analysed. The results presented here
suggest that the effect of membrane fluidity on the interactions
with erythrocyte or brain spectrin also depends on the way this
parameter is regulated.
2. Materials and methods
2.1. Materials
Sephacryl S-500-HR, DEAE-Sephacel, Sepharose 4-B, DTT, EGTA, PI,
DMPE, DPPE, PSPE and rhodamine isothiocyanate were obtained from Sigma
Chemical Co. (St. Louis, MO). Egg PC, egg PE, DMPC, DPPC and DSPC
were from Lipids Products (Nutfield, UK). Cholesterol and DMSO were from
Merck (Darmstadt, Germany). DOPC and DOPE were from Northern Lipids
Inc. (Vancouver, Canada). The other reagents were from ICN.
2.2. Methods
Brain (tetrameric) and erythrocyte (dimeric) spectrins were purified and
their purity was assessed as described previously ([8] and references therein).
Monolayer measurements were performed by using a Teflon trough (surface
area of 24 cm2) and a Nima tensiometer ST 9000 (Nima Technology, Coventry
UK), at room temperature (20 -C), and filter paper plates were used. A
subphase buffer (25 ml), containing 5 mM Tris/HCl, pH 7.5, 0.5 mM EDTA,
150 mM NaCl, 0.5 mM DTT and 1 mM NaN3, was stirred with a small stirrer
bar (52 mm). Monolayers were formed by injecting a chloroform solution ofa phospholipid mixture with a Hamilton syringe into the subphase buffer. After
stabilisation (10–20 min) of the monolayer at the desired initial surface pres-
sure (8–14 mN/m), aliquots (5 Al) of brain or red blood cell spectrin dialysed
against the above-mentioned buffer were injected into the subphase, and
surface pressure (p) measurements were taken. The data points represent the
average values of several independent experiments with an average variation
not larger than 10%. It should be noted that this method, although fast and
useful, gives only comparative results demonstrating the interaction of the
protein with the lipid, as the measurements were performed at low initial
surface pressure values, far from the 30–35 mN/m suggested as appropriate for
comparison with natural membranes [17].
For the pelleting assays, purified erythrocyte spectrin was labelled with
rhodamine isothiocyanate. The protein was dialysed against a 0.1 M sodium
carbonate buffer, pH 9.0, and a DMSO solution of the rhodamine isothiocya-
nate (1 mg/ml; 50 Al for each 1 ml of protein solution) was added. After
overnight incubation in the dark at 4 -C, Tris was added to the mixture (to a
final concentration of 100 mM), and after a 2-h incubation at 4 -C, glycerol and
sucrose were added (to respective final concentrations of 5% and 0.5 M). The
mixture was dialysed against the buffer described above as the subphase buffer
for 48 h through 3–4 buffer changes. After such a procedure, less than 1% of
the fluorescence could be measured in the supernatant after protein
precipitation with 10% trichloroacetic acid. Also, the binding of labelled spect-
rin was inhibited by unlabelled protein: at 10-fold excess, ¨70% inhibition of
binding was observed.
Frozen and thawed (FAT) liposomes were prepared according to [18] using
the ‘‘subphase’’ buffer containing 20% Dextran T40, and the spectrin binding
assay was carried out as described previously [9]. The diameter (¨400 nm, as
measured by Photon Correlation Spectrometry) of the liposomes did not change
significantly within even weeks of storage at 4 -C. The obtained pellets were
dissolved in 2 ml 1% SDS and fluorescence measurements were taken in a
Kontron spectrofluorimeter at excitation and emission wavelengths of 553 and
575 nm, respectively.
3. Results
To test whether changes in fluidity have an effect on the
interaction of erythrocyte and brain spectrin with phospholipid
monolayers, we used two different methods of changing mo-
nolayer fluidity: (1) we changed the cholesterol concentration
in the mixtures of natural PE/PC (3:2) and PI/PC (7:3) phos-
pholipids (cholesterol is well known to increase the fluidity of
a gel phase and to decrease it in a liquid crystal phase
phospholipid mono- and bilayers, i.e., below Tm it increases
the fraction of gauche rotamers while opposite is seen above
Tm) and 2) we used synthetic phospholipid mixtures—DMPE/
DMPC, DPPE/DPPC, DSPE/DSPC and DOPE/DOPC—to
form a monolayer.
The dependence of the surface pressure changes of a natural,
egg PE/PC monolayer containing various amounts of choles-
terol on erythrocyte spectrin (dimeric form) concentration in
the subphase is shown in Fig. 1A. It should be noted that highly
hydrated egg PE/PC (3:2) mixture has its transition temperature
below the temperature of measurements (20 -C) [19]. Thus,
addition of cholesterol decreased its fluidity. To facilitate
comparison, the values observed for each cholesterol content in
this monolayer at the chosen spectrin concentration of 1.56 nM
are shown in Fig. 1B. The baseline in this case is the Dp value
obtained for pure PE/PC monolayer. The addition of erythro-
cyte spectrin to the subphase buffer induced a larger increase in
the surface pressure (Dp) of PE/PC monolayers containing
5% and 10% cholesterol than seen for monolayers without
cholesterol. The values for other cholesterol concentrations
Fig. 1. Changes in the surface pressure (Dp) of the PE/PC 3/2 monolayer containing increasing concentrations of cholesterol after the addition of erythrocyte
spectrin to the subphase. (A) Dependence on erythrocyte spectrin concentration at initial surface pressure (pi): 8–9 mN/m. The values of the surface pressure
change induced by the protein without a lipid monolayer were subtracted from Dp. (B) Dependence on cholesterol content at an erythrocyte spectrin
concentration of 1.56 nM in the subphase at indicated initial surface pressure (pi) values. The value of Dp change for the monolayer without cholesterol is
considered 0.
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observed for monolayers without cholesterol (Fig. 1B).
Another characteristic feature of this interaction is that for
monolayers containing cholesterol, the Dp increases only at
low concentrations of erythrocyte spectrin (up to 2–2.5 nM),
and then decreases well below the values observed for the
spectrin without a lipid monolayer (Fig. 1A). These results
were similar both for smaller (8–9 mN/m) and for larger
(10–11 mN/m) pi values (see Fig. 1B).
Similar experiments performed on brain spectrin (Fig. 2)
indicate that the presence of cholesterol modifies the interac-
tion of brain spectrin with a given monolayer to a greater extent
than observed for erythroid spectrin (compare Figs. 1 and 2).
The values observed for each cholesterol content in this
monolayer at the chosen brain spectrin concentration of
3.95 nM (brain spectrin always occurs as a tetramer) are
shown in Fig. 2B. For both smaller and larger values of pi, anFig. 2. Changes in the surface pressure (Dp) of the PE/PC 3/2 monolayer containing
subphase. (A) Dependence on brain spectrin concentration at initial surface pressu
protein without a lipid monolayer were subtracted from Dp. (B) Dependence on cho
indicated initial surface pressure (pi) values. The value of Dp change for the monoincrease in the surface pressure change of a monolayer
prepared from PE/PC with cholesterol was larger than that
for a monolayer without cholesterol; a relatively symmetrical
peak was obtained around 20% cholesterol. The exceptions are
the values for 5 and 50% cholesterol at a pi of 10–11 mN/m;
these were identical to the control values (Fig. 2B). It also
seems that the change in this parameter in the case of erythroid
spectrin is less sensitive to the value of pi (compare data from
Figs. 1B and 2B).
The changes in surface pressure of the PI/PC (7/3)
monolayer containing variable concentrations of cholesterol
upon the increase of the concentrations erythrocyte or brain
spectrin in the subphase are shown in Figs. 3A and 4A,
respectively. As the data are presented in a similar format to
Figs. 1B and 2B, it can clearly be seen that in the case of
erythroid spectrin, there was a double peak for the effect at 5%
and 30% cholesterol, while in the case of non-erythroidincreasing concentrations of cholesterol after the addition of brain spectrin to the
re (pi): 8–9 mN/m. The values of the surface pressure change induced by the
lesterol content at a brain spectrin concentration of 3.95 nM in the subphase at
layer without cholesterol is considered 0.
Fig. 3. The effect of cholesterol on erythrocyte spectrin interaction with the PI/PC 7/3 monolayer. (A) Dependence of Dp on erythrocyte spectrin concentration at a p i
of 8–9 mN/m. The values of the surface pressure change induced by the protein without a lipid monolayer were subtracted from Dp. (B) Dependence of the Dp
value on cholesterol content in the monolayer at an erythrocyte spectrin concentration of 3.95 nM in the subphase at the indicated initial surface pressure (pi) values.
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(Figs. 3B and 4B). This is similar to the effect of cholesterol on
the PE/PC monolayer (see above). All the Dp change values
observed for erythroid spectrin were larger in the presence of
cholesterol than in its absence (Fig. 3B), while only the peak
values of Dp change (at 20–30% cholesterol) were larger when
brain spectrin was added to the subphase (Fig. 4B).
In order to test whether the observed changes depend on
fluidity or rather on lateral phase heterogeneity, we performed a
small set of experiments to test the interaction of red blood cell
and brain spectrin with phospholipid monolayers containing
PE and PC at a 3:2 ratio, composed of homogenous synthetic
lipids containing C14, C16 and C18 saturated, and C18
unsaturated fatty acyl chains, namely: DMPE/DMPC, DPPE/
DPPC, DSPE/DSPC and DOPE/DOPC. The results of these
experiments performed similarly to those presented above
(Figs. 1–4) are shown in Figs. 5 and 6. For clarity, only the
values of Dp at one spectrin concentration, 3 nM for erythroid
spectrin (Fig. 5) and 2.8 nM for brain spectrin (Fig. 6), are
shown (plateau level). The sequence of bars reflects anFig. 4. The effect of cholesterol on brain spectrin interaction with the PI/PC 7/3 mono
m. The values of the surface pressure change induced by the protein without a lip
cholesterol content in the monolayer at a spectrin concentration of 3.95 nM in theincreasing transition temperature of particular phospholipid
mixtures. In general, the injection of erythrocyte spectrin into
the subphase buffer induced a smaller increase in the surface
pressure of the above-mentioned monolayers compared to the
results obtained for the natural PE/PC monolayers (see Fig. 5).
The smallest Dp change was observed for the DMPE/DMPC
monolayer film at pi ¨8 and for the DOPC/DOPE monolayer
across the whole range of pi values. Larger changes were
observed for the DPPE/DPPC mixture, but for the DSPE/DSPC
(6/4) monolayer, the obtained values were similar to or even
higher than those for the natural PE/PC monolayer (note the
data obtained for higher initial surface pressures, Fig. 5). When
brain spectrin was injected into the subphase, the surface
pressure change is proportional to the transition temperature
being the largest in the case of DSPE/DSPC monolayers
(see Fig. 6).
Taking into consideration the results presented above, it
can be concluded that the effect of the changes in monolayer
fluidity on spectrin–monolayer interactions induced by the
presence of cholesterol differs from the effects of thoselayer. (A) Dependence of Dp on brain spectrin concentration at a p i of 8–9 mN/
id monolayer were subtracted from Dp. (B) Dependence of the Dp value on
subphase at indicated initial surface pressure (pi) values.
Fig. 5. Change in the surface pressure (Dp) of the synthetic phospholipid mixture monolayers DMPE/DMPC (3/2), DPPE/DPPC (3/2), DSPE/DSPC (3/2) and
DOPE/DOPC (3/2) after the addition of erythrocyte spectrin to the subphase, at the indicated initial surface pressure (pi) values, in comparison with natural PE/PC
(3/2) monolayers at p i =9.5. The values of the surface pressure change induced by the protein without a lipid monolayer were subtracted from Dp. Red blood cell
spectrin concentration in the subphase: 3 nM.
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degree of saturation of the phospholipids forming the
monolayer.
In the context of the results of experiments addressing the
effect of the fluidity of lipids forming the monolayer, it is
interesting to test the interaction of spectrins with monolayers
composed from a lipid mixture resembling that of membrane
rafts. Fig. 7 presents the dependence of the surface pressure
change on the initial surface pressure of a monolayer composed
from a ‘‘raft-like’’ lipid mixture: SM, DOPC and cholesterol at
a 1:1:1 weight ratio [14,15]. An increase in Dp was observed
after the addition of erythrocyte spectrin into the subphase, but
the obtained values (Dp change max. 2–2.5 mN/m over the
value of the protein alone level) were much smaller than those
observed for the natural PE/PC monolayer, i.e. 6–7 mN/m
above the level for protein alone [10]. A similar dependence of
Dp change on pi could be observed for brain spectrin (Fig. 8).
After the addition of brain spectrin into the subphase buffer, theFig. 6. Change in the surface pressure (Dp) of the synthetic phospholipid mixture
DOPE/DOPC (3/2) after the addition of brain spectrin to the subphase, at indicate
monolayers at p i =9.4. The values of the surface pressure change induced by the
concentration in the subphase: 2.78 nM.observed Dp change was max. 2–3 mN/m compared to max.
6–7 mN for the natural PE/PC monolayer [10].
In order to test whether the above results can be compared
with the results obtained in the pelleting assays, we performed
binding assays using rhodamine isothiocyanate-labelled eryth-
rocyte spectrin and FAT liposomes (see Materials and
methods) prepared from DMPE/DMPC (6/4), DPPE/DPPC
(6/4), DSPE/DSPC (6/4) (Fig. 9A) and cholesterol/SM/DOPC
(1:1:1) (Fig. 9B), and from a natural PE/PC (6/4) mixture
containing 0, 10, 20 and 50% cholesterol (Fig. 9C). The
binding isotherms at pH 7.5 for the phospholipid liposomes
described above are shown in Fig. 9A–C. Saturable binding
of erythrocyte spectrin to FAT liposomes with the equilibrium
dissociation constants in the nanomolar to submicromolar
range was observed in all cases (Fig. 9). The presented data
indicate that the differences in Dp changes observed for the
monolayer experiment are rather connected with the changes
in the maximal binding capacity, as the changes in equilib-monolayers DMPE/DMPC (3/2), DPPE/DPPC (3/2), DSPE/DSPC (3/2) and
d initial surface pressure (pi) values, in comparison with natural PE/PC (3/2)
protein without a lipid monolayer were subtracted from Dp. Brain spectrin
Fig. 7. Change in the surface pressure (Dp) of monolayers formed from a SM/DOPC/cholesterol (1/1/1) mixture as a function of the initial surface pressure (p i) after
the addition of erythrocyte spectrin into the subphase; for comparison, the Dp changes for PE/PC (3/2) monolayers (dashed lines) are inserted. Erythrocyte spectrin
concentrations in the subphase are indicated by the following symbols: 0.64 (+), 1.9 (q), 2.52 (o), 3.74 (.), 4.96 (g) nM.
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fluidity (Fig. 9A and B) were not substantial. On the other
hand, when cholesterol was included in the lipid mixture, a
change between 0 and 10% was significant (¨5-fold increase
in KD value), while the differences in KD observed for the
various cholesterol contents were rather moderate (within one
order of magnitude). It is interesting that a high affinity (¨54
nM) was observed for FAT liposomes prepared from the
‘‘raft-like’’ mixture of lipids.
4. Discussion
Our results indicate that increasing concentrations of
cholesterol in the monolayer facilitate the penetration of the
monolayer by spectrins: in the case of erythroid spectrin, the
maximum is observed at 10% and for brain spectrin,
the maximum is at 20% cholesterol. For comparison, we
performed assays on erythrocyte spectrin binding FAT lipo-
somes prepared from a PE/PC mixture containing 10, 20 orFig. 8. Change in the surface pressure (Dp) of monolayers formed from a SM/DOPC
the addition of brain spectrin into the subphase; for comparison, the Dp chan
concentrations in the subphase are indicated by the following symbols: 0.63 (+), 150% cholesterol (Fig. 9C). It seems that the different
cholesterol contents of the liposomes primarily affected the
maximal binding capacity (Bmax) while the affinities remained
within one order of magnitude the same. The only substantial
difference in KD observed for 0 and 10% cholesterol in
liposomal membrane.
It was previously reported that the effect of brain spectrin on
monolayers composed from anionic phospholipids and their
mixtures with PC was much larger than that observed in the case
of erythrocyte spectrin [20]. The results presented above indicate
that the inclusion of cholesterol into a PI/PC mixture also
changes the effect of each spectrin on the monolayer surface
pressure. Moreover, the maximum of effect of the brain spectrin
is at 20–30% cholesterol, while for the erythrocyte spectrin, two
maxima (at 5 and at 30% cholesterol) can be observed. The
above data, in particular for brain spectrin, concur with the
physiological concentration of the cholesterol in the membrane,
which varies between 24% and 29%. According to Radhakrish-
nan et al. [21,22] three coexisting liquid phases could be/cholesterol (1/1/1) mixture as a function of the initial surface pressure (p i) after
ges for PE/PC (3/2) monolayers (dashed lines) are inserted. Brain spectrin
.56 (q), 2.78 (o), 3.95 (.), 4.81 (g) nM.
Fig. 9. Binding of increasing concentrations of rhodamine isothiocyanate-labelled erythrocyte spectrin by FAT-liposomes prepared from: (A) DMPE/DMPC 3/2 (q),
DPPE/DPPC 3/2 (o), DSPE/DSPC 3/2 (.); (B) Cholesterol/SM/DOPC 1/1/1 (q); (C) A PE/PC 3/2 mixture containing 10% cholesterol (q), 20% cholesterol (o),
50% cholesterol (.) and a PE/PC 3/2 mixture without cholesterol (0). Binding assay carried out at pH 7.5. Error bar=TS.D. Equilibrium dissociation constants
calculated by nonlinear regression are shown in the legend. Other details in Materials and methods.
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phospholipids with long, saturated acyl chains: a phospholipid-
rich phase, a condensed cholesterol/phospholipid complex-rich
phase and a cholesterol-rich phase [22]. The existence of a
cholesterol/phospholipid complex is indicated by the presenceof two upper miscibility points [23]. Although the phase
diagrams of the monolayer prepared from specific phospholipid
mixtures with cholesterol are not available, we may anticipate
that the cholesterol-facilitated ability of spectrin to penetrate the
monolayer could be a result of the segregation of lipids into
W. Diakowski et al. / Biochimica et Biophysica Acta 1758 (2006) 4–12 11small domains (or phases) [22]; therefore, the phase borders
could function as ‘‘binding sites’’ for spectrins. The presence of
themaxima at similar cholesterol contents could substantiate this
assumption. In such a case, each spectrin could ‘‘sense’’ different
kind of defects in the monolayer. This in particular concerns the
charged phospholipid monolayer, which was reported to yield
more complex phase diagrams [23].
The conclusion that the above effect of cholesterol is not
simply the result of the change in membrane fluidity is
supported by the results of experiments with monolayers
constructed from homogenous synthetic phospholipids, which
indicated an increase in the Dp change correlating with the
increased acyl chain length of the phospholipids used to
prepare the monolayer (Figs. 5 and 6). The obtained results
indicate that the effect of erythrocyte spectrin on the monolayer
containing homogenous fatty acyl chains was generally smaller
(with the exception of the DSPE/DSPC monolayer at pi of
11 mN/m) than that on the natural PE/PC monolayer. In
particular, it is interesting that for the synthetic lipid monolayer,
the Dp increased with increasing pi, unlike in the case of brain
spectrin, for which decreasing values of Dp change with
increasing pi were observed. Again, the results from the
pelleting assays carried out for erythroid spectrin confirm that
the changes concern maximal binding capacity rather than af-
finity (Fig. 9A). All synthetic phospholipids with the exception
of DOPE/DOPC were in the gel phase at the temperature of the
measurements. The surface pressure changes induced by both
spectrins were much smaller for DOPE/DOPC than for
monolayers prepared from other mixtures phospholipids used
in the experiments. (Figs. 5 and 6). In the case of monolayers
prepared from synthetic phospholipids, our data show a clear
dependence of the surface pressure change (Dp) on the lipids’
acyl chain length and saturation, implying that the higher the
transition point, the larger the effect of either spectrin.
Although the monolayer experiments could not mimic the
natural membrane bilayer, as the measurements were per-
formed at low surface pressure values, it showed the changes in
binding capacities for spectrins depended on the way the
fluidity of the monolayer is changed. The data seem to concur
with that obtained via the pelleting assay using liposomes
which better mimic the natural membrane bilayer.
Differences in structural and physical properties between
sphingolipids and phospholipids in their ability to compress
hydrophobic chains could promote the phase separation in the
membrane. The presence of cholesterol, in particular its
condensed complexes with SM [22], facilitates the formation
of membrane domains called rafts, characterised by the
occurrence of highly ordered acyl chains. It remains unclear
whether a raft’s lipids interact directly with spectrin, or if raft
proteins are needed. There is evidence that spectrin, actin,
protein 4.1 and protein 4.2 could partially associate with lipid
rafts [24], but this is a rather weak association [25]. On the
other hand, it is likely that the membrane-associated skeleton
plays a major role both in the regulation of the size and in the
lateral positioning of the rafts [26]. In experiments with raft-
like monolayers constructed from DOPC, SM and cholesterol
(1/1/1), we observed an increase in the surface pressure afterthe addition of erythrocyte and brain spectrin into the subphase.
However, the obtained values of Dp change were much smaller
than those observed in the case of the natural PE/PC (6/4)
monolayer. On the other hand, the results of the pelleting
assays indicate that red blood cell spectrin binds FAT
liposomes prepared from these lipids in a saturable manner
with a KD of 54+14 nM. This could further support the view
that the presence of domains and domain borders would
promote interaction with spectrin.
Some laboratories reported that the formation of lipid rafts in
the outer leaflet of the bilayer could have an effect on the
behaviour of lipids in the inner leaflet of the same bilayer
[22,27]. It is known that the presence of PE, the main
component of the inner leaflet, in the phospholipid mixture
could promote the formation of rafts, even within one
monolayer [28]. This result for the first time indicates an
interaction of spectrins with membranes prepared from a raft-
like mixture of lipids.
In conclusion, it can be supposed that the effect of
membrane lipid layer fluidity is not simple but depends on
the way of its regulation, i.e., the cholesterol content or the
chemical structure of the membrane lipids.Acknowledgements
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